Impact of Engineered Nanomaterials on Health: Considerations for Benefit-Risk Assessment
This policy report is the result of the first strategic liaison between the JRC and EASAC and provides independent, cross-referenced, science-based analysis of the impact of nanomaterials on human health. The report is directed at European and national policy-makers and citizens. Nanomaterials have the potential to play a major role in European innovation, economic growth and industrial competitiveness. In order to capitalise on this technology and reap the promised benefits, the EU must ensure the appropriate framework for its success. A key element in this regard concerns a harmonised assessment of the safety of nanomaterials and this requires a strengthened dialogue between policy-makers and scientists.
|Source:||European Commission Joint Research Centre|